U.S. Markets closed

TRACON Pharmaceuticals, Inc. (TCON)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.8900-0.2800 (-8.83%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.88
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 312.2000
52 Week Low 32.3700
50-Day Moving Average 33.5996
200-Day Moving Average 35.7375

Share Statistics

Avg Vol (3 month) 3147.36k
Avg Vol (10 day) 3232.78k
Shares Outstanding 515.5M
Implied Shares Outstanding 6N/A
Float 813.94M
% Held by Insiders 11.34%
% Held by Institutions 147.83%
Shares Short (Sep 14, 2021) 4302.53k
Short Ratio (Sep 14, 2021) 41.77
Short % of Float (Sep 14, 2021) 42.29%
Short % of Shares Outstanding (Sep 14, 2021) 41.56%
Shares Short (prior month Aug 12, 2021) 4545.65k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 07, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Nov 07, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)-6,308.67%

Management Effectiveness

Return on Assets (ttm)-64.27%
Return on Equity (ttm)-299.05%

Income Statement

Revenue (ttm)346k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-8.2M
EBITDA -21.82M
Net Income Avi to Common (ttm)-22.31M
Diluted EPS (ttm)-1.5410
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)25.58M
Total Cash Per Share (mrq)1.32
Total Debt (mrq)3.16M
Total Debt/Equity (mrq)26.53
Current Ratio (mrq)1.76
Book Value Per Share (mrq)1.32

Cash Flow Statement

Operating Cash Flow (ttm)-16.93M
Levered Free Cash Flow (ttm)-8.5M